Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Neoplasm Metastasis 13Squamous Cell Carcinoma of Head and Neck 11Neoplasms 11Prostatic Neoplasms 10Breast Neoplasms 9Recurrence 7Ovarian Neoplasms 7Myasthenia Gravis 7Lung Neoplasms 7Leukemia, Myeloid, Acute 7Stomach Neoplasms 6Head and Neck Neoplasms 6Colorectal Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Fatigue 5Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Melanoma 4Fallopian Tube Neoplasms 4Colonic Neoplasms 4Urinary Bladder Neoplasms 3Rectal Neoplasms 3Peritoneal Neoplasms 3Mouth Neoplasms 3Glioblastoma 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Anorexia 3Adenocarcinoma Of Esophagus 3

Interventions

fluorocholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Parathyroid Neoplasms × 90 days × Clear all
NCT07444723 2026-05-12

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2/3 Recruiting
193 enrolled
EndocrineHead & Neck

Parathyroid Neoplasms, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡